BHI Therapeutic Sciences

About BHI Therapeutic Sciences

BHI Therapeutic Sciences, a subsidiary of the renowned Blue Horizon International, stands at the forefront of regenerative medicine, offering cutting-edge stem cell therapies to patients from across the globe. With a primary facility located in the serene setting of Montego Bay, Jamaica, and a corporate and research presence in the United States, BHI has established itself as a leader in the field, driven by a mission to provide the highest quality treatments at the most affordable cost. The clinic’s philosophy is rooted in a unique blend of therapy, research, and philanthropy, a model that has allowed it to make significant strides in the field of regenerative medicine. BHI is committed to a science-driven approach, with a world-class Scientific Advisory Board that guides its research endeavors. The company is actively involved in multiple research projects, including a U.S. FDA Investigational New Drug (IND) trial for stroke, which underscores its dedication to advancing medical science. The clinic in Montego Bay, Jamaica, provides a tranquil and healing environment for patients. It is designed to be a state-of-the-art, GMP-certified facility, ensuring the highest standards of safety and quality. Patients have the option to stay on-site or in nearby accommodations, making the treatment process as comfortable and convenient as possible.

BHI’s approach to patient care is highly personalized. The clinic’s team of U.S. board-certified physicians and medical professionals works closely with each patient to develop a tailored treatment plan. The patient experience is an outpatient one, with procedures that are virtually painless and typically take only a few hours. The clinic offers a wide range of stem cell therapies for various conditions, including neurologic disorders, autoimmune diseases, and orthopedic conditions. BHI utilizes ethically sourced stem cells, primarily from umbilical cord blood and adipose tissue, and has a proven track record of safety and efficacy, with over 4,000 successful therapies to date. The company’s commitment to affordability is a key aspect of its mission. BHI strives to make these life-changing therapies accessible to as many people as possible, offering treatments at the lowest cost point in the market. This commitment, combined with its dedication to research and patient care, has positioned BHI Therapeutic Sciences as a global leader in regenerative medicine, offering hope and healing to patients from all walks of life.

Clinic Information

Treatments Offered

Medical Team

Frequently Asked Questions